参考文献/References:
[1] YOSHIDA G J.Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways[J]. J Exp Clin Cancer Res,2020,39(1): 112.
[2] KURO O M. The Klotho proteins in health and disease[J]. Nat Rev Nephrol, 2019,15(1): 27-44.
[3] FANG D, ZHANG C F,XU P,et al. S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1/2 pathways[J]. Cell Biology and Toxicology, 2021,37(4):555-571.
[4] HOSHI T, MIYANO S W,WATANABE H,et al. Lenvatinib induces death of human hepatocellular carcinoma cells harboring an activated FGF signaling pathway through inhibition of FGFR-MAPK cascades[J]. Biochem Biophys Res Commun, 2019,513(1): 1-7.
[5] HU L L,CONG L X.Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer[J]. Oncol Rep, 2015,34(5):2683-2691.
[6] WAG D Y,ZHANG J J,LI Z J,et al. Upregulation of fibroblast growth factor 19 is associated with the initiation of colorectal adenoma[J]. Dig Dis, 2019,37(3): 214-225.
[7] KATOH M, NAKAGAMA H. FGF receptors: cancer biology and therapeutics[J].Medicinal Research Reviews, 2014, 34(2):280-300.
[8] ZHANG X C,KONG M,ZHANG Z,et al. FGF19 genetic amplification as a potential therapeutic target in lung squamous cell carcinomas[J]. Thoracic Cancer, 2017,8(6): 655-665.
[9] KANG H J,HAQ F,SUNG C O,et al. Characterization of hepatocellular carcinoma patients with FGF19 amplification assessed by fluorescence in situ hybridization: a large cohort study[J]. Liver Cancer, 2019,8(1): 12-23.
[10] FENG S,DANKHOVA O,CREIGHTON C J,et al. Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression[J].Cancer Research, 2013,73(8):2551-2562.
[11] AGARWAL S,AFAQ F,BAJPAI P,et al. DCZ0415, a small-molecule inhibitor targeting TRIP13, inhibits EMT and metastasis via inactivation of the FGFR4/STAT3 axis and the Wnt/β-catenin pathway in colorectal cancer[J]. Molecular Oncology, 2022,16(8): 1728-1745.
[12] YE Y W,JIANG D B,LI J J,et al. Silencing of FGFR4 could influence the biological features of gastric cancer cells and its therapeutic value in gastric cancer[J]. Tumor Biology, 2015,37(3): 3185-3195.
[13] TIONG K H,TAN B S,CHOO H L,et al.Fibroblast growth factor receptor 4(FGFR4)and fibroblast growth factor 19(FGF19)autocrine enhance breast cancer cells survival[J]. Oncotarget, 2016,7(36):57633-57650.
[14] GAO L X,LANG L W,ZHAO X D,et al.FGF19 amplification reveals an oncogenic dependency upon autocrine FGF19/FGFR4 signaling in head and neck squamous cell carcinoma[J]. Oncogene, 2018,38(13): 2394-2404.
相似文献/References:
[1]杨国华 郑圣斌 林彩锋 黄若磊.肿瘤相关成纤维细胞经FGF19/FGFR4信号轴调控结肠癌细胞生长的实验研究[J].福建医药杂志,2020,42(04):136.
YANG Guohua,ZHENG Shengbin,LIN Caifeng,et al.Experimental study on CAF regulating the growth of colorectal cancer through the signal axis of fibroblast growth factor 4/fibroblast growth factor 19[J].FUJIAN MEDICAL JOURNAL,2020,42(05):136.
[2]陈惠珍,吴芙蓉,陈颖娇.ERAS理念指导下的护理干预在老年单孔加一孔腹腔镜结肠癌根治术围手术期中的应用[J].福建医药杂志,2024,46(02):150.[doi:10.20148/j.fmj.2024.02.044]